BISHOP
Phase NA Recruiting
617 enrolled
FASTRAK
Phase NA Recruiting
944 enrolled
Kirros
Phase 2 Recruiting
30 enrolled
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
Recruiting
40 enrolled
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Phase 2 Recruiting
72 enrolled
LivMOD
Recruiting
800 enrolled
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Phase 2/3 Recruiting
12 enrolled
PREMIUM
Phase NA Recruiting
4,700 enrolled
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Recruiting
45 enrolled
REVISE-HCC
Phase NA Recruiting
600 enrolled
AMULET
Recruiting
300 enrolled
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Phase 4 Recruiting
100 enrolled
Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
Phase NA Recruiting
204 enrolled
CTMH
Phase NA Recruiting
5 enrolled
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Recruiting
5,000 enrolled
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
Recruiting
1,500 enrolled
Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma
Recruiting
159 enrolled
LSM
Phase NA Recruiting
150 enrolled
LIVERATION
Phase 3 Recruiting
471 enrolled
VOCAL2
Recruiting
750 enrolled
FIBROTHERME
Phase NA Recruiting
110 enrolled
Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)
Recruiting
120 enrolled
CIBERbBECHO
Phase 3 Recruiting
1,000 enrolled
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
Phase 2 Recruiting
40 enrolled
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
20,000 enrolled
The European NAFLD Registry
Recruiting
10,000 enrolled
Pearl
Recruiting
3,000 enrolled
HepatoPredict
Phase NA Recruiting
40 enrolled
EU-PNAFLD
Recruiting
2,000 enrolled
PROMETEO
Recruiting
5,000 enrolled